SILVER STD RES INC's ticker is SSRI and the CUSIP is 82823L106. A total of 121 filers reported holding SILVER STD RES INC in Q4 2016. The put-call ratio across all filers is 0.81 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $258,000 | -51.8% | 24,286 | -59.5% | 0.01% | -69.8% |
| Q4 2016 | $535,000 | +35.1% | 59,933 | +82.7% | 0.04% | +87.0% |
| Q3 2016 | $396,000 | +182.9% | 32,803 | +30.2% | 0.02% | +130.0% |
| Q1 2016 | $140,000 | -83.9% | 25,196 | -81.1% | 0.01% | -80.8% |
| Q3 2015 | $868,000 | +108.2% | 133,146 | +100.7% | 0.05% | +126.1% |
| Q2 2015 | $417,000 | -76.1% | 66,329 | -81.0% | 0.02% | -83.9% |
| Q4 2014 | $1,747,000 | +1072.5% | 348,981 | +1331.9% | 0.14% | +1330.0% |
| Q3 2014 | $149,000 | – | 24,372 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Syntal Capital Partners, LLC | 17,540 | $167,000 | 0.12% |